Hologic Aktie
WKN: 879100 / ISIN: US4364401012
|
02.05.2025 00:33:23
|
Hologic Posts Q2 Loss On Impairment Charges Despite Stable Revenue
(RTTNews) - Hologic, Inc. (HOLX) Thursday reported a net loss for the fiscal second quarter ended March 29, driven by significant impairment charges, despite largely stable revenue year over year.
The company posted a net loss of $17.4 million, or $0.08 per share, compared to net income of $169.9 million, or $0.72 per share, in the same quarter last year. The decline was primarily due to $220.9 million in impairment charges on intangible assets, compared to $26.8 million in the prior-year period.
Revenue for the quarter came in at $1.01 billion, slightly down from $1.02 billion a year earlier. Product revenue declined to $792.7 million from $828.0 million, while service and other revenue rose to $212.6 million from $189.8 million.
Operating income swung to a loss of $7.0 million from a profit of $210.4 million in the previous year, as the impairment and higher general and administrative expenses weighed on results.
HOLX closed Thursday's trading at $57.28 down $0.92 or 1.58 percent on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Hologic IncShsmehr Nachrichten
Analysen zu Hologic IncShsmehr Analysen
Aktien in diesem Artikel
| Hologic IncShs | 63,50 | 0,00% |
|